Attenuation of oxidative stress and alteration of hepatic tissue ultrastructure by D-pinitol in streptozotocin-induced diabetic rats

Free Radical Research

Volumn 44, Issue 6, 2010, Pages 668-678

  Sivakumar, Selvaraj ^a   Palsamy, Periyasamy ^a   Subramanian, Sorimuthu Pillai ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

D pinitol; Diabetes mellitus; Lipid peroxidation; Oxidative stress; Pro inflammatory cytokines; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; CYTOKINE; DEXTRO PINITOL; GLICLAZIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROPEROXIDE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDE; LIVER ENZYME; NITRIC OXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIVER; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; TISSUE STRUCTURE; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INOSITOL; LIVER; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN;

RATTUS;

EID: 77953553534     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715761003733901     Document Type: Article

References (78)

1. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. I V. Antioxidant defense system. Free Radic Biol Med 1997; 22:587-592.
2. Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987;36:1014-1018.
3. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990;13:610-630.
4. Yki-J ä rvinen H. Glucose toxicity. Endocr Rev 1992;13: 415-431.
5. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 1988;256:205-212.
6. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-352.
7. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Lef è bvre PJ. Metabolic control may infl uence the increased superoxide generation in diabetic serum. Diabet Med 1991;8:540-542.
8. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
9. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17:171-180.
10. R ö sen P, Nawroth PP, King G, M ö ller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001;17:189-212.
11. Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann NY Acad Sci 1989;570:7-22.
12. Phillips DV, Dougherty DE, Smith AE. Cyclitols in soybean. J Agric Food Chem 1982;30:456-458.
13. Streeter JG. Carbohydrates in soybean nodules: II. distribution of compounds in seedlings during the onset of nitrogen fi xation. Plant Physiol 1980;66:471-476.
14. Phillips DV, Smith AE. A rapid method for gas chromato-graphic analysis of mono-and disaccharide mixtures. Anal Biochem 1973;54:95-101.
15. Schweizer TF, I Horman, P Wursch. Low molecular weight carbohydrates from leguminous seeds: a new disaccharide: galactopinitol. J Sci Food Agric 1978;29:148-154
16. Ford CW. Accumulation of low molecular weight solutes in water-stressed tropical legumes. Phytochemistry 1984;23: 1007-1015.
17. Guo C, Oosterhuis DM. Effect of water-defi cit stress and genotypes on pinitol occurrence in soybean plants. Environ Exp Bot 1997;37:147-152.
18. Paul MJ, Cockburn W. Pinitol, a compatible solute in Mesembryanthemum crystallinum L.? J Exp Bot 1989;40: 1093-1098.
19. Numata A, Hokimoto K, Shimada A, Yamaguchi H, Takaishi K. Plant constituents biologically active to insects I\feedings stimulants for the larva of the yellow butterfl y Eurema hecabe mandarina. Chem Pharm Bull 1979;27:602-608.
20. Singh RK, Pandey BL, Tripathi M, Pandey VB. Anti-infl ammatory effect of (+)-pinitol. Fitoterapia 2001;72:168-170.
21. Kim JI, Kim JC, Kang MJ, Lee MS, Kim JJ, Cha IJ. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 2005;59:456-458
22. Geethan PK, Prince PS. Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic Wistar rats. J Biochem Mol Toxicol 2008;22:220-224.
23. Greenwood M, Kreider RB, RasMussen C, Almada AL, Earnest CP. D-Pinitol augments whole body creatine retention in man. J Exer Physiol 2001;4:41-47.
24. Sivakumar S, Subramanian SP D-pinitol attenuates the impaired activities of hepatic key enzymes in carbohydrate metabolism of streptozotocin-induced diabetic rats. Gen Physiol Biophys 2009;28:233-241.
25. Sivakumar S, Subramanian SP. Pancreatic tissue protective nature of D-Pinitol studied in streptozotocin-mediated oxidative stress in experimental diabetic rats. Eur J Pharmacol 2009;622:65-70.
26. Stadler K, Jenei V, von B ö lcsh á zy G, Somogyi A, Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med 2003;35: 1240-1251.
27. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the dia-betogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963;29:91-98.
28. Fischer LJ, Rickert DE. Pancreatic islet-cell toxicity. CRC Crit Rev Toxicol 1975;3:231-263.
29. Nayak SS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chim Acta 1981;109:267-274.
30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fl uids. Anal Biochem 1982;126:131-138.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
32. Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fl uids. Methods Enzymol 1979;62:3-11.
33. Desai ID. Vitamin E analysis methods for animal tissues. Methods Enzymol 1984;105:138-147.
34. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman ' s reagent. Anal Biochem 1968;25:192-205.
35. Okawa H, Doi K. Neoplastic lesions in streptozotocin-treated rats. Jikken Dobutsu 1983;32:77-84.
36. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992;202:384-389.
37. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-3175.
38. Takahara S, Hamilton HB, Neel JV, Kobara TY, Ogura Y, Nishimura ET. Hypocatalasemia: a new genetic carrier state. J Clin Invest 1960;39:610-619.
39. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-590.
40. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The fi rst enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
41. Vavra JJ, Deboer C, Dietz A, Hanka LJ, Sokolski WT. Strep-tozotocin, a new antibacterial antibiotic. Antibiot Annu 1959;7:230-235.
42. O ' Brien RM, Granner DK. Regulation of gene expression by insulin. Physiol Rev, 1996, 76, 1109-1161.
43. Kr ö ncke KD, Fehsel K, Sommer A, Rodriguez ML, Kolb-Bachofen V. Nitric oxide generation during cellular metaboliza-tion of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage. Biol Chem Hoppe Seyler 1995;376:179-185.
44. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
45. Baynes J W. Chemical modifi cation of proteins by lipids in diabetes. Clin Chem Lab Med 2003;41:1159-1165.
46. Eriksson UJ, Sim á n CM. Pregnant diabetic rats fed the anti-oxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 1996;45:1497-1502.
47. Meerson FZ, Kagan VE, Kozlov YuP, Belkina LM, Arkhipenko YuV. The role of lipid peroxidation in pathogen-esis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982;77:465-485.
48. O ' Brien BA, Harmon BV, Cameron DP, Allan DJ. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 1996; 178:176-181.
49. Evans JL, Goldfi ne ID, Maddux BA, Grodsky GM. Are oxida-tive stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003;52:1-8.
50. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
51. Lasker RD. The diabetes control and complications trial. Implications for policy and practice. N Engl J Med 1993; 329:1035-1036.
52. Tilg H. Cytokines and liver diseases. Can J Gastroenterol 2001;15:661-668.
53. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G. Markers of infl ammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999;353:1649-1652.
54. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998;14:129-151.
55. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-1149.
56. Giannopoulou I, Fernhall B, Carhart R, Weinstock RS, Baynard T, Figueroa A, Kanaley JA. Effects of diet and/or exercise on the adipocytokine and infl ammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005;54:866-875.
57. Morales A, Garc í a-Ruiz C, Miranda M, Mar í M, Colell A, Ardite E, Fern á ndez-Checa JC. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma-glutamylcysteine synthetase. J Biol Chem 1997;272:30371-30379.
58. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 2005;360:9-26.
59. Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T. Interleukin 1beta and inter-leukin 6, but not tumor necrosis factor alpha, inhibits insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 1998;27:1296-1303.
60. Gowen M, Wood DD, Ihrie EJ, McGuire MK, Russell RG. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983;306:378-380. (Pubitemid 14242749)
61. Firestein GS, Yeo M, Zvaifl er NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-1638.
62. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 1993;13:3301-3310.
63. Vieira EC, Carneiro EM, Latorraca MQ, Delguingaro-Augusto V, Amaral ME, Bosqueiro JR, Boschero AC. Low protein diet confers resistance to the inhibitory effects of interleukin 1beta on insulin secretion in pancreatic islets. J Nutr Biochem 2001;12:285-291.
64. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 1997;138:2610-2614.
65. Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003;311:372-379.
66. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594-1603.
67. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-1916.
68. Baynes J W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
69. Jessup W, Dean RT, de Whalley CV, Rankin SM, Leake DS. The role of oxidative modifi cation and antioxidants in LDL metabolism and atherosclerosis. Adv Exp Med Biol 1990;264:139-142.
70. Chou PT, Khan AU. L-ascorbic acid quenching of singlet delta molecular oxygen in aqueous media: generalized antioxidant property of vitamin C. Biochem Biophys Res Commun 1983;115:932-937.
71. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983;52:711-760.
72. rd. Effects of isoeug-enol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15: 159-164.
73. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1995;18:833-840.
74. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.
75. McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991;40:344-348.
76. rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38.
77. Mat é s JM, S á nchez-Jim é nez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci. 1999, 4, D339-D345.
78. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-L173.